SymbolBSX
NameBOSTON SCIENTIFIC CORP
SectorHEALTH CARE
RegionNorth America
IndustrySurgical & Medical Instruments & Apparatus
Address300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA 01752-1234
Telephone508-683-4000
Fax
Email
Websitehttps://www.bostonscientific.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0000885725
Description

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firms total sales.

Additional info from NASDAQ:
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firms total sales.

2026-07-29 10:33

(90% Positive) BOSTON SCIENTIFIC CORP (BSX) Announces Enrollment Update for innovation Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Read more
2026-07-29 10:30

Boston Scientific announces results for second quarter 2026

Read more
2026-07-16 22:00

Belo Sun Reports on New Court Proceedings Regarding the Volta Grande Gold Project

Read more
2026-07-02 20:07

Monson Jonathan 🟡 adjusted position in 1.0K shares (1 derivative) of BOSTON SCIENTIFIC CORP (BSX) at $43.06 Transaction Date: Jul 01, 2026 | Filing ID: 006362

Read more
2026-06-30 11:00

Belo Sun Provides Project Update

Read more
2026-06-24 17:06

New Form 11-K - BOSTON SCIENTIFIC CORP <b>Filed:</b> 2026-06-24 <b>AccNo:</b> 0000885725-26-000046 <b>Size:</b> 1 MB

Read more
2026-06-08 11:00

Belo Sun Announces Management Transition

Read more
2026-06-01 20:18

Director Mahoney Michael F 🔴 sold 386.8K shares of BOSTON SCIENTIFIC CORP (BSX) Transaction Date: May 28, 2026 | Filing ID: 005670

Read more
2026-06-01 11:30

Belo Sun Announces Corporate Update

Read more
2026-05-26 22:00

Belo Sun Announces 2026 Shareholder Meeting Voting Results and Corporate Update

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT00136929 Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardi… Na Myocardial Infarction Unknown ClinicalTrials.gov
NCT00887055 OPTIMA Bi-ventricular Capture Verification Study Heart Failure Withdrawn ClinicalTrials.gov
NCT01227785 Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardia… Sudden Cardiac Death Completed 2010-10-01 2011-12-01 ClinicalTrials.gov
NCT01143220 Japanese Assessment of Indication Based Programming Heart Failure Completed 2010-08-01 2012-09-01 ClinicalTrials.gov
NCT00920452 The 4-SITE Field Following Study (4-SITE FF) ICD and CRT-D Indicated Patients Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00800384 Shockless Implant Evaluation Na Ventricular Fibrillation Completed 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00833352 Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in P… Na Systolic Heart Failure Completed 2008-11-01 2011-12-01 ClinicalTrials.gov
NCT00711893 Feature Assessment Study for Indications Based Programming Ventricular Tachycardia Completed 2008-06-01 2010-02-01 ClinicalTrials.gov
NCT00606710 Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site)… Ventricular Tachycardia, Ventricular Fibrillation Completed 2008-02-01 2008-10-01 ClinicalTrials.gov
NCT00409604 PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From… Phase2 Acute Myocardial Infarction Completed 2006-12-01 2009-08-01 ClinicalTrials.gov
NCT00335036 Pediatric Lead Extractability and Survival Evaluation (PLEASE) Na Ventricular Tachycardia Terminated 2006-06-01 2009-01-01 ClinicalTrials.gov
NCT00305526 REBEAT Resynchronisation and Beta-Blocker European Trial Phase4 Heart Failure Terminated 2006-04-01 2007-07-01 ClinicalTrials.gov
NCT00848341 Canadian Registry of ICD Implant Testing Procedures Ventricular Fibrillation Completed 2006-01-01 2008-11-01 ClinicalTrials.gov
NCT00257309 Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients Phase4 Acute Myocardial Infarction Terminated 2005-04-01 2008-12-01 ClinicalTrials.gov
NCT00180297 Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Def… Na Ventricular Tachycardia Completed 2005-04-01 2012-09-01 ClinicalTrials.gov
NCT00848653 ELECTION - The Electrode Configuration Cardiac Resynchronization Therapy (CRT) … Heart Failure Completed 2004-11-01 2008-12-01 ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00180414 MODULA Modul 7 VRR Na Atrial Fibrillation Terminated 2004-08-28 2008-05-07 ClinicalTrials.gov
NCT00164190 Routine Angioplasty and Stenting After Fibrinolysis for Acute Myocardial Infarc… Na Myocardial Infarction Completed 2004-07-01 2009-01-01 ClinicalTrials.gov
NCT00180362 Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and A… Phase4 Cardiac Arrest Completed 2004-05-01 2004-09-01 ClinicalTrials.gov
NCT00279175 REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI) Phase3 Myocardial Infarction Completed 2004-04-01 2010-12-01 ClinicalTrials.gov
NCT00116792 PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Sten… Phase2 Coronary Artery Disease Unknown 2004-03-01 ClinicalTrials.gov
NCT00180531 Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With t… Phase4 Congestive Heart Failure Completed 2004-02-01 2007-06-01 ClinicalTrials.gov
NCT00180609 SCANCAP Scandinavian Automatic Capture Study Bradycardia Completed 2003-12-01 2006-07-01 ClinicalTrials.gov
NCT00273091 MODULA Modul 5 BEAT-HF Heart Failure Completed 2003-08-01 2007-05-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00180440 INSURE: INcidence Free SUrvival Before and After Implantable Cardioverter Defib… Ventricular Fibrillation Completed 2002-07-01 2008-11-01 ClinicalTrials.gov
NCT00180401 MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex… Heart Failure Terminated 2002-06-01 2007-10-01 ClinicalTrials.gov
NCT00848835 Long Term Integrity Follow-up Evaluation Sudden Cardiac Death Completed 2002-03-01 2010-01-01 ClinicalTrials.gov
NCT00180427 VERRARI - "Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs… Phase4 Ventricular Fibrillation Completed 2001-06-01 2004-11-01 ClinicalTrials.gov
NCT00180570 SALT - Success of Active Versus Passive Lead Fixation of Atrial Pacing/Sensing … Phase4 Bradycardia Suspended 1997-01-01 2006-01-01 ClinicalTrials.gov
NCT00475449 The Stent or Surgery (SoS) Trial Na Coronary Artery Disease Completed 1996-11-01 2006-02-01 ClinicalTrials.gov
Total clinical trials: 32
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Contak Renewal (CRT-D) Other Phase PHASE4 Heart Failure TERMINATED NCT00305526
Renewal TR2 Other Phase PHASE4 Congestive Heart Failure COMPLETED NCT00180531
Renewal TR2 Other Phase PHASE4 Congestive Heart Failure COMPLETED NCT00180531
Percutaneous Coronary Intervention (PCI) Other Phase PHASE2 Coronary Artery Disease UNKNOWN NCT00116792
Percutaneous Coronary Intervention (PCI) Other Phase PHASE2 Coronary Artery Disease UNKNOWN NCT00116792
Routine Early Percutaneous Coronary Intervention after Thrombolysis Other Approved Myocardial Infarction COMPLETED NCT00164190
ICD Other Phase PHASE4 Ventricular Fibrillation COMPLETED NCT00180427
CRT device Device Preclinical Heart Failure COMPLETED NCT00848653
CRT device Device Preclinical Heart Failure COMPLETED NCT00848653
GUIDANT ICD SYSTEM Other Preclinical Ventricular Fibrillation COMPLETED NCT00848341
ICD Other Preclinical Ventricular Fibrillation COMPLETED NCT00180440
Automatic threshold test in Insignia Pacemakers from Guidant Other Preclinical Bradycardia COMPLETED NCT00180609
defibrillation lead (ENDOTAK EZ and RELIANCE) Other Preclinical Sudden Cardiac Death COMPLETED NCT00848835
defibrillation lead (ENDOTAK EZ and RELIANCE) Other Preclinical Sudden Cardiac Death COMPLETED NCT00848835
Temporary RV VVI pacing Other Phase PHASE2 Acute Myocardial Infarction COMPLETED NCT00409604
INCEPTA ICD or CRT-D Other Preclinical Sudden Cardiac Death COMPLETED NCT01227785
FineLine II Sterox, FineLine II Sterox, FineLine II Sterox EZ Other Phase PHASE4 Bradycardia SUSPENDED NCT00180570
FineLine II Sterox, FineLine II Sterox, FineLine II Sterox EZ Other Phase PHASE4 Bradycardia SUSPENDED NCT00180570
CRT device Device Preclinical Heart Failure WITHDRAWN NCT00887055
CRT device Device Preclinical Heart Failure WITHDRAWN NCT00887055
Total products: 20